About: Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $0.40 (-10.49%)
CODX NASDAQ Co-Diagnostics, Inc. Common Stock
Co-Diagnostics, Inc. Common Stock share price
Atividade de preço de CODX
Último preço
$ 0,400
Variação (24h)
-0,05 USD (10,49%)
Volume
529.14K
Volume (média 4 sem.)
-
Abertura
$ 0,45
Variação do dia
$ 0,39 - $ 0,45
Fechamento anterior
$ 0,44
Último negócio
29 Oct, 8:09 pm GMT+0
Atrasado
29 Oct, 8:09 pm GMT+0
CODX price performance
Atrasado
29 Oct, 8:09 pm GMT+0
quote.marketSignals